Pharmaceutical News

RSS

Temozolomide sales reach $1 billion

Sales of Temozolomide, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion.

8 Feb 2009

Medicines sold in Sweden cause serious environmental harm in India

Many of the substances in our most common medicines are manufactured in India and China.

8 Feb 2009

New guideline for prescribing opioid pain drugs published

A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.

8 Feb 2009

Medications control metabolism dominate spending for prescription meds

Medications that affect a person's metabolism by helping to lower cholesterol, control diabetes and control weight accounted for $38 billion of the $208.1 billion that American adults spent on medications in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality (AHRQ).

8 Feb 2009

Idenix Pharmaceuticals and GSK sign agreement for novel NNRTI for treatment of HIV

Idenix Pharmaceuticals, Inc. and GlaxoSmithKline (GSK) today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899.

8 Feb 2009

FDA approves orphan drug ATryn anticoagulant

The U.S. Food and Drug Administration has issued its first approval for a biological product produced by genetically engineered (GE) animals.

8 Feb 2009

Emergency physicians question antibiotic guidelines for pneumonia

A new study from Wake Forest University Baptist Medical Center that assessed emergency physicians understanding of time-based, antibiotic treatment guidelines for community-acquired pneumonia (CAP) found that more than half believed they prescribed antibiotics needlessly in order to comply with guidelines.

8 Feb 2009

Abbott's acquisition of Advanced Medical Optics clears U.S. antitrust review

Abbott has announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) applicable to Abbott's cash tender offer to purchase all of the outstanding shares of common stock of Advanced Medical Optics (AMO) expired last night at 11:59 p.m. Eastern time.

8 Feb 2009

FDA issues early communication about Xigris safety

The U.S. Food and Drug Administration has announced that it is working with the maker of Xigris (drotrecogin alfa activated), Eli Lilly and Company, to further evaluate the incidence of serious bleeding events and death in patients who receive Xigris, a drug used to treat severe sepsis (a blood stream infection).

5 Feb 2009

FDA grants priority review of Cinryze C1 inhibitor as treatment for acute attacks of hereditary angioedema

ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted priority review for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of Hereditary Angioedema (HAE).

5 Feb 2009

New vaccine developed for preventing human adenovirus type-3d virus

Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind.

2 Feb 2009

FDA approves KAPIDEX (dexlansoprazole) capsules for the treatment of GERD

Patients with leg pain caused by arterial disease may be able to forego treatment of the affected artery by participating in hospital-supervised exercise, according to a new study published in the February issue of Radiology.

2 Feb 2009

Chronic lung disease progress report from Axentis Pharma

Axentis Pharma AG is to present its recent successes in developing and financing a new therapeutic formulation for treating chronic lung disease at the 2nd Annual European Life Science CEO Forum in Zurich, Switzerland.

2 Feb 2009

Bioidentical hormone facts and perspectives

Public confusion of the benefits and risks of hormone therapy was highlighted once again this week on The Oprah Winfrey Show.

2 Feb 2009

Melanotan I and Melanotan II linked to rapidly changing moles

Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .

29 Jan 2009

Discounted prescription drugs online becoming more attractive to many

Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.

29 Jan 2009

FDA warns consumers not to take Venom HYPERDRIVE 3.0

The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine.

29 Jan 2009

Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203

Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology.

29 Jan 2009

Mylan receives final FDA approvals for generic Lamictal tablets

Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Applications (ANDAs) for Lamotrigine Tablets.

29 Jan 2009

SAFC Pharma augments assay development capabilities

SAFC Pharma, a business segment of SAFC, a member of the Sigma-Aldrich group, today announced that it has commenced operations at its 7,000 sq. ft. state-of-the-art laboratory complex in Carlsbad, CA.

29 Jan 2009